Intervention

Study Drug

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast CancerNCT02538471 · 2015-08-10

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy AdultsNCT02201849 · 2014-07-01

Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)NCT01270711 · 2010-11-01

Common conditions

Hyperprolactinemia1 Metastatic Breast Cancer1 Multiple Sclerosis1 Parkinson's Disease1

Leading sponsors

Biogen1 Pfizer1 Weill Medical College of Cornell University1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.